SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has rescheduled its annual meeting of stockholders to Tuesday, July 31, 2012, at 2:00 p.m. Pacific. The previously scheduled date was July 25.
